Heidenreich A - Search Results

1

Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3-Year Open Label Followup Results.

Tombal B, Borre M, Rathenborg P, Werbrouck P, Van Poppel H, Heidenreich A, Iversen P, Braeckman J, Heracek J, Baron B, Krivoshik A, Hirmand M, Smith MR. Tombal B, et al. Among authors: heidenreich a. J Urol. 2018 Feb;199(2):459-464. doi: 10.1016/j.juro.2017.08.103. Epub 2017 Sep 1. J Urol. 2018. PMID: 28867562 Clinical Trial.

2

The influence of ejaculation on serum levels of prostate specific antigen.

Heidenreich A, Vorreuther R, Neubauer S, Westphal J, Engelmann UH, Moul JW. Heidenreich A, et al. J Urol. 1997 Jan;157(1):209-11. J Urol. 1997. PMID: 8976253

3

Testis-preserving surgery in bilateral testicular germ cell tumours.

Heidenreich A, Höltl W, Albrecht W, Pont J, Engelmann UH. Heidenreich A, et al. Br J Urol. 1997 Feb;79(2):253-7. doi: 10.1046/j.1464-410x.1997.33418.x. Br J Urol. 1997. PMID: 9052478

4

Cryoablation of localized prostate cancer. Experience in 48 cases, PSA and biopsy results.

Derakhshani P, Neubauer S, Braun M, Zumbé J, Heidenreich A, Engelmann U. Derakhshani P, et al. Among authors: heidenreich a. Eur Urol. 1998 Sep;34(3):181-7. doi: 10.1159/000019709. Eur Urol. 1998. PMID: 9732189

5

The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer.

Heidenreich A, Hofmann R, Engelmann UH. Heidenreich A, et al. J Urol. 2001 Jan;165(1):136-40. doi: 10.1097/00005392-200101000-00033. J Urol. 2001. PMID: 11125382 Clinical Trial.

6

Current status of cytotoxic chemotherapy in hormone refractory prostate cancer.

Heidenreich A, von Knobloch R, Hofmann R. Heidenreich A, et al. Eur Urol. 2001 Feb;39(2):121-30. doi: 10.1159/000052426. Eur Urol. 2001. PMID: 11223670 Review.

7

EAU guidelines on prostate cancer.

Aus G, Abbou CC, Bolla M, Heidenreich A, Schmid HP, van Poppel H, Wolff J, Zattoni F; European Association of Urology. Aus G, et al. Among authors: heidenreich a. Eur Urol. 2005 Oct;48(4):546-51. doi: 10.1016/j.eururo.2005.06.001. Eur Urol. 2005. PMID: 16046052 Review.

8

Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.

Heidenreich A, Richter S, Thüer D, Pfister D. Heidenreich A, et al. Eur Urol. 2010 Mar;57(3):437-43. doi: 10.1016/j.eururo.2009.02.041. Epub 2009 Mar 13. Eur Urol. 2010. PMID: 19303197

9

Testosterone measurement in patients with prostate cancer.

Schulman CC, Irani J, Morote J, Schalken JA, Montorsi F, Chlosta PL, Heidenreich A. Schulman CC, et al. Among authors: heidenreich a. Eur Urol. 2010 Jul;58(1):65-74. doi: 10.1016/j.eururo.2010.04.001. Eur Urol. 2010. PMID: 20434831 Review.

10

Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trials.

Peinemann F, Grouven U, Bartel C, Sauerland S, Borchers H, Pinkawa M, Heidenreich A, Lange S. Peinemann F, et al. Among authors: heidenreich a. Eur Urol. 2011 Nov;60(5):881-93. doi: 10.1016/j.eururo.2011.06.044. Epub 2011 Jun 29. Eur Urol. 2011. PMID: 21763066 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

792 results

Search Page

Filters